November 2024 Roundup

November 2024 Roundup

Incase you missed it...

News | GlycoNex announces manufacturing agreement with Sterling for GNX102-ADC clinical trial production

GlycoNex Inc., a clinical stage biotechnology company, has today announced its partnership with Sterling for the clinical trial production of its antibody drug conjugate, GNX102.

Click to read more.


Blog | Full Time Equivalent (FTE)

Choosing a full time equivalent (FTE) for your project can support you in overcoming project challenges, whilst building a collaborative, responsive and flexible partnership.

Click to find out more about the advantages of having an FTE as part of your team.


Infographic | Mitigating risk, maximising reward

As more complex molecules enter the pipeline, the demand for hazardous chemistry has seen a significant increase.

Click here to find out more as our experts discuss how you can maximise safety and success in hazardous process design.


Where to find Sterling:

?? BioFIT 2024 | 3rd-4th December | Lille, France

?? 2025 Healthcare Conference, JP Morgan | 13th-16th January | San Francisco, US

?? World ADC Europe | 3rd-6th March | London, UK

Hardeep Chawla

Enterprise Sales Director at Zoho | Fueling Business Success with Expert Sales Insights and Inspiring Motivation

2 个月

Super impressive!

要查看或添加评论,请登录

Sterling Pharma Solutions的更多文章

社区洞察

其他会员也浏览了